論文－吉武 忠正
Clinicopathological evaluation of pre-operative chemoradiotherapy with S-1 as a treatment for locally advanced oral squamous cell carcinoma.
Kawano S, Zheng Y, Oobu K, Matsubara R, Goto Y, Chikui T, Yoshitake T, Kiyoshima T, Jinno T, Maruse Y, Mitate E, Kitamura R, Tanaka H, Toyoshima T, Sugiura T, Nakamura S.
Oncol Lett. 2016 May;11(5):3369-3376.
Prognostic Significance of a Minute Amount of Ascites During Chemoradiotherapy for Locally Advanced Pancreatic Cancer.
Shinoto M, Nakamura K, Shioyama Y, Sasaki T, Nishie A, Asayama Y, Ohga S, Yoshitake T, Terashima K, Asai K, Matsumoto K, Honda H.
Anticancer Res. 2016 Apr;36(4):1879-84.
Treatment Planning Comparison for Carbon Ion Radiotherapy, Proton Therapy and Intensity-modulated Radiotherapy for Spinal Sarcoma.
Matsumoto K, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Yamaguchi T, Yoshitake T, Asai K, Kakiuchi G, Honda H.
Anticancer Res. 2015 Jul;35(7):4083-9.
Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma–Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System.
Ohga S, Nakamura K, Shioyama Y, Sasaki T, Yamaguchi T, Yoshitake T, Terashima K, Asai K, Matsumoto K, Honda H.
Anticancer Res. 2015 Jun;35(6):3591-7.
Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience.
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Shinoto M, Terashima K, Asai K, Matsumoto K, Matsuo Y, Baba S, Honda H.
Int J Clin Oncol. 2015 Feb;20(1):53-8.
Impact of Interstitial Changes on Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer.
Yoshitake T, Shioyama Y, Asai K, Nakamura K, Sasaki T, Ohga S, Kamitani T, Yamaguchi T, Ohshima K, Matsumoto K, Kawanami S, Honda H.
Anticancer Res. 2015 Sep;35(9):4909-13.
Thermographic visualization of the superficial vein and extravasation using the temperature gradient produced by the injected materials.
Nakamura K, Sasaki T, Ohga S, Yoshitake T, Terashima K, Asai K, Matsumoto K, Shinoto M, Shioyama Y, Nishie A, Honda H.
Infrared Phys Tech 67:514–520, 2014
The Effect of Treatment Position on Rectal and Bladder Dose-Volume Histograms for Prostate Radiotherapy Planned with 3-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy.
Terashima K, Nakamura K, Sasaki, T, Ohga, S, Yoshitake T, Atsumi K, Shinoto M, Asai K, Matsumoto K, Hirata H, Shioyama Y, Nishie A and Honda H.
Int J Med Phys Clin Eng Radiat Oncol 3:88-97, 2014
Acute urinary morbidity after a permanent 125I implantation for localized prostate cancer.
Ohga S, Nakamura K, Shioyama Y, Tatsugami K, Sasaki T, Nonoshita T, Yoshitake T, Asai K, Hirata H, Naito S, Honda H.
J Radiat Res. 55(6):1178-83, 2014.
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
Okamoto D, Nishie A, Asayama Y, Tajima T, Ishigami K, Kakihara D, Nakayama T, Ohga S, Yoshitake T, Shioyama Y, Honda H.
Magn Reson Imaging. 32(6):660-4, 2014.
Definitive fractionated re-irradiation for local recurrence following stereotactic body radiotherapy for primary lung cancer.
Yoshitake T, Shioyama Y, Nakamura K, Sasaki T, Ohga S, Shinoto M, Terashima K, Asai K, Matsumoto K, Hirata H, Honda H.
Anticancer Res. 33(12):5649-53, 2013.
Radiotherapy for early-stage primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Ohga S, Nakamura K, Shioyama Y, Sasaki T, Yoshitake T, Atsumi K, Terashima K, Asai K, Matsumoto K, Yoshikawa H, Kawano Y, Honda H.
Anticancer Res. 33(12):5575-8, 2013.
Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.
Matsumoto K, Sasaki T, Shioyama Y, Nakamura K, Atsumi K, Nonoshita T, Ooga S, Yoshitake T, Uehara S, Hirata H, Honda H.
Jpn J Clin Oncol. 43(10):1012-7, 2013.
Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors.
Shinoto M, Shioyama Y, Nakamura K, Nakashima T, Kunitake N, Higaki Y, Sasaki T, Ohga S, Yoshitake T, Ohnishi K, Asai K, Hirata H, Honda H.
J Radiat Res. 54(5):925-30, 2013.
Can a belly board reduce respiratory-induced prostate motion in the prone position?–assessed by cine-magnetic resonance imaging.
Terashima K, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Atsumi K, Asai K, Hirakawa M, Anai S, Yoshikawa H, Honda H.
Technol Cancer Res Treat. 12(5):447-53, 2013
Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.
Atsumi K, Nakamura K, Abe K, Hirakawa M, Shioyama Y, Sasaki T, Baba S, Isoda T, Ohga S, Yoshitake T, Shinoto M, Asai K, Honda H.
J Radiat Res. 54(5):890-8, 2013.
Stereotactic body radiation therapy for stage I non-small cell lung cancer patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy.
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Terashima K, Asai K, Matsumoto K, Honda H.
Anticancer Res 32(9):4041-4.2012
Computerized estimation of patient setup errors in portal images based on localized pelvic templates for prostate cancer radiotherapy.
Arimura H, Itano W, Shioyama Y, Matsushita N, Magome T, Yoshitake T, Anai S, Nakamura K, Yoshidome S, Yamagami A, Honda H, Ohki M, Toyofuku F, Hirata H.
J Radiat Res 53(6):961-72, 2012
Radiation-Induced Rib Fractures After Hypofractionated Stereotactic Body Radiation Therapy: Risk Factors and Dose-Volume Relationship.
Asai K, Shioyama Y, Nakamura K, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Ohnishi K, Terashima K, Matsumoto K, Hirata H, Honda H.
Int J Radiat Oncol Biol Phys 84(3):768-73, 2012
Esophageal stenosis associated with tumor regression in radiotherapy for esophageal cancer: frequency and prediction.
Atsumi K, Shioyama Y, Arimura H, Terashima K, Matsuki T, Ohga S, Yoshitake T, Nonoshita T, Tsurumaru D, Ohnishi K, Asai K, Matsumoto K, Nakamura K, Honda H.
Int J Radiat Oncol Biol Phys 82(5):1973-80, 2012
Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma.
Ohnishi K, Shioyama Y, Hatakenaka M, Nakamura K, Abe K, Yoshiura T, Ohga S, Nonoshita T, Yoshitake T, Nakashima T, Honda H.
J Radiat Res 52(4):522-30, 2011
Concurrent chemoradiotherapy with S-1 as first-line treatment for patients with oropharyngeal cancer.
Ohnishi K, Shioyama Y, Nakamura K, Nakashima T, Ohga S, Nonoshita T, Yoshitake T, Terashima K, Komune S, Honda H.
J Radiat Res 52(1):47-53, 2011
Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
Nonoshita T, Shioyama Y, Nakamura K, Nakashima T, Ohga S, Yoshitake T, Ohnishi K, Terashima K, Asai K, Honda H.
J Radiat Res 51(4):481-4, 2010
Chemoradiation for small cell esophageal carcinoma: report of 11 cases from multi-institution experience.
Atsumi K, Shioyama Y, Nomoto S, Ohga S, Toba T, Sasaki T, Kunitake N, Yoshitake T, Nakamura K, Honda H.
J Radiat Res 51(1):15-20, 2010.
Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer.
Atsumi K, Shioyama Y, Nakamura K, Nomoto S, Ohga S, Yoshitake T, Nonoshita T, Ueda M, Hirata H, Honda H.
J Radiat Res 51(1):9-14, 2010
A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location.
Yoshitake T, Shioyama Y, Nakamura K, Ohga S, Nonoshita T, Ohnishi K, Terashima K, Arimura H, Hirata H, Honda H.
Phys Med Biol 54(23):7171-82, 2009.
膠芽腫の放射線治療後の増悪形式とその無増悪期間、生存期間との関連について.
吉武忠正, 塩山善之, 中村和正, 野元諭, 樋渡昭雄, 吉浦敬, 平田秀紀, 松本俊一, 溝口昌弘, 庄野禎久, 佐々木富男, 本田浩.
臨床放射線 54(5):631-636, 2009
Cortical thickness difference across the central sulcus visualized in the presence of vasogenic edema.
Togao O, Yoshiura T, Mihara F, Noguchi T, Hiwatashi A, Yamashita K, Yoshitake T, Honda H.
Eur J Radiol 66(2):274-81, 2008.
Breath-hold monitoring and visual feedback for radiotherapy using a charge-coupled device camera and a head-mounted display: system development and feasibility.
Yoshitake T, Nakamura K, Shioyama Y, Nomoto S, Ohga S, Toba T, Shiinoki T, Anai S, Terashima H, Kishimoto J, Honda H.
Radiat Med 26(1):50-5, 2008.
Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors.
Shioyama Y, Nakamura K, Ohga S, Nomoto S, Sasaki T, Yamaguchi T, Toba T, Yoshitake T, Terashima H, Honda H.
Jpn J Clin Oncol 37(12):918-23, 2007.
Treatment of early tongue carcinoma with brachytherapy: results over a 25-year period.
Urashima Y, Nakamura K, Shioyama Y, Nomoto S, Ohga S, Toba T, Yoshitake T, Chikui T, Kawazu T, Jingu K, Terashima H, Honda H.
Anticancer Res 27(5B):3519-23, 2007.
肺腫瘍に対する体幹部定位放射線治療における回転原体照射法の有用性の検討.
椎木健裕, 中村和正, 塩山善之, 野元諭, 大賀才路, 鳥羽隆史, 吉武忠正, 本田浩.
臨床放射線 52(5):705-709, 2007
Reproducibility of the abdominal and chest wall position by voluntary breath-hold technique using a laser-based monitoring and visual feedback system.
Nakamura K, Shioyama Y, Nomoto S, Ohga S, Toba T, Yoshitake T, Anai S, Terashima H, Honda H.
Int J Radiat Oncol Biol Phys 68(1):267-72, 2007.
Low pre-radiotherapy prostate-specific antigen level is a significant predictor of treatment success for postoperative radiotherapy in patients with prostate cancer.
Sasaki T, Nakamura K, Shioyama Y, Ohga S, Toba T, Urashima Y, Yoshitake T, Terashima H, Koga H, Naito S, Noma H, Komatsu K, Yamaguchi A, Hiratsuka Y, Hirano T, Hanada K, Abe M, Fujisawa Y, Honda H.
Anticancer Res 26(3B):2367-74, 2006.
Computer-aided nodule detection on digital chest radiography: validation test on consecutive t1 cases of resectable lung cancer.
Sakai S, Soeda H, Takahashi N, Okafuji T, Yoshitake T, Yabuuchi H, Yoshino I, Yamamoto K, Honda H, Doi K.
J Digit Imaging 19(4):376-82, 2006.
A machine vision system with CCD cameras for patient positioning in radiotherapy: a preliminary report.
Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Yamaguchi T, Toba T, Anai S, Terashima H, Honda H.
Fukuoka Igaku Zasshi 96(12):399-405, 2005.
Stereotactic radiotherapy for lung and liver tumors using a body cast system: setup accuracy and preliminary clinical outcome.
Shioyama Y, Nakamura K, Anai S, Sasaki T, Ooga S, Saku M, Urashima Y, Yoshitake T, Toba T, Terashima H, Honda H.
Radiat Med 23(6):407-13, 2005.
Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx.
Nakamura K, Shioyama Y, Sasaki T, Ohga S, Saku M, Urashima Y, Yoshitake T, Nakashima T, Kuratomi Y, Komune S, Terashima H, Honda H.
Int J Radiat Oncol Biol Phys 62(3):680-3, 2005.
Fitz-Hugh-Curtis syndrome. Radiologic manifestation.
Nishie A, Yoshimitsu K, Irie H, Yoshitake T, Aibe H, Tajima T, Shinozaki K, Nakayama T, Kakihara D, Matsuura T, Takahashi M, Kamochi N, Onitsuka H, Honda H.
J Comput Assist Tomogr 27(5):786-91, 2003.
Fitz-Hugh-Curtis syndrome: CT所見の検討.
吉武忠正, 西江昭弘, 松浦隆志, 高橋信, 吉満研吾, 入江裕之, 相部仁, 田嶋強, 篠崎賢治, 中山智博, 柿原大輔, 本田浩.
日本医学放射線学会誌 63(6):303-7, 2003.